Amide proton transfer MR imaging in peritoneal metastasis evaluation by Lee, EYP et al.
Title Amide proton transfer MR imaging in peritoneal metastasisevaluation
Author(s) Yu, X; Lee, EYP; Chan, Q; Kim, M
Citation
The 21st Annual Meeting and Exhibition of the International
Society for Magnetic Resonance in Medicine (ISMRM) and SMRT
22nd Annual Meeting, Salt Lake City, UT., 20-26 April 2013. In
Conference Proceedings, 2013, v. 21, p. 2533
Issued Date 2013
URL http://hdl.handle.net/10722/186714
Rights Creative Commons: Attribution 3.0 Hong Kong License
Amide Proton Transfer MR Imaging in Peritoneal Metastasis Evaluation 
Xue Yu1, Elaine Yuen Phin Lee1, Queenie Chan2, and Mina Kim1 
1Diagnostic Radiology, The University of Hong Kong, Hong Kong, China, 2Philips Healthcare, Hong Kong, China 
 
Target audience This abstract contains information of interest to radiologists, oncologists, and other professionals working with chemical 
exchange saturation transfer (CEST) or in the field of MRI. 
 
Purpose Cytoreductive surgery has emerged as a neoadjuvant treatment to intraperitoneal and hyperthermic chemotherapy, which are potentially 
effective in controlling local disease. Therefore evaluation of peritoneal dissemination is essential for early diagnosis and treatment planning. 
MRI has been used in peritoneal metastasis imaging, with gadolinium-enhanced MRI sensitive in depicting peritoneal disseminations of small 
volume. CEST MRI is a novel molecular imaging technique that is able to assess the concentration of mobile proteins and peptides indirectly 
through bulk water signals. CEST MRI using amide protons as contrast agent, termed as amide proton transfer (APT) has been applied in tumor 
imaging, as the concentration of mobile amide protons increases in malignant tissues1. APT MRI can provide complementary information to 
current MR sequences used in clinical practice in peritoneal metastasis 
imaging. The purpose of this study is to assess APT MRI at 3 Tesla in 
peritoneal metastasis evaluation. 
 
Methods 
Six patients (male: female=1:2, mean age of 56±6 years) with suspected 
peritoneal metastases were recruited for MRI scans. Peritoneal 
dissemination was confirmed by histology in three patients, the remaining 
three patients had radiological follow-ups for verification of the peritoneal 
metastasis. Axial CEST images were acquired by a 3T Achieva scanner (Philips Healthcare, Best, the Netherland) using single-slice turbo spin 
echo (TSE) sequence (imaging parameters: TR/TE=3000/60ms, slice thickness=7mm, voxel size=2×2mm2, total scan time=3min 39sec; RF 
saturation pulse: 300ms and 1.5μT). CEST data with 33 offsets were collected with presaturation pulses from -8 to 8ppm with 0.5ppm interval 
with respect to water resonance. Another 3 data sets without saturation were acquired and averaged. Before data analysis, B0 field inhomogeneity 
correction was applied using CEST data according to method published previously2. Regions of interest (ROIs) were contoured over tumor, and 
2 pixel ×2 pixel ROI over fat and muscle. Mean of the magnetic transfer ratio asymmetry (MTRasym) within the selected ROIs were integrated 
over the 3-4 ppm as the resonance of amide protons is at 3.5ppm with respect to water resonance. 
 
Results 
A total of 8 peritoneal metastases in 6 patients were analyzed. Fig. 1 shows a typical APT 
color map of one of the peritoneal metastasis in the left pelvis, and lesion has good separation 
from its surrounding tissue. The integrated mean MTRasym for peritoneal metastases was 
0.85%±0.94%, which was significantly different from that of fat (10.40%±1.43%, p<0.001) 
and that of muscle (-2.02%±1.48%, p<0.001), as illustrated in Fig. 2. 
 
Discussion  
After B0 field inhomogeneity correction, no large spatial signal fluctuation was observed in the 
APT map covering the pelvic region (Fig. 1b). The symmetrical APT signals over muscle and 
fat suggested that inhomogeneity correction was efficient and the APT value for peritoneal 
metastasis was reliable.  The significant differences in APT value between peritoneal 
metastasis, fat and muscle indicated that APT MRI was feasible in aiding the detection of 
peritoneal dissemination especially when the metastases are close or adherent to fat or soft 
tissue.  
 
Conclusions 
This pilot study demonstrates the feasibility of APT MRI in differentiating peritoneal metastases from fat and muscle. This is clinically relevant 
as peritoneal metastases can be deposited in the area with abundant fat or adherent to soft tissue; therefore separation of these different tissue 
compositions will aid detection and assessment of peritoneal metastases.  
 
References 
[1] Jia G, Abaza R, Williams JD, et al. Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging. Mar 
2011;33(3):647-654. [2] Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC. Water saturation shift referencing (WASSR) for chemical 
exchange saturation transfer (CEST) experiments. Magn Reson Med. Jun 2009;61(6):1441-1450. 
 
 
10% 
 
Fig. 1 APT color map of left peritoneal metastasis (arrow) 
superimposed on raw APT image (a) and whole APT color map (b). 
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Fig. 2 Mean integrated MTRasym of peritoneal 
metastasis, fat and muscle in percentage. 
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